S21-382 Potential First-In-Class Neuroprotective Agents and Therapeutic Target for Treatment of Glaucoma; Optic Neuropathies The Hu Lab at Stanford has identified several FDA-approved small molecule medicines with neuroprotective effects on glaucoma. Yang Hu Wei Chen